This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.
Description, Dosage, Side Effects, Contraindications. Data from EMA, URPL, openFDA and other regulatory sources.
| Diclofenac | Ibuprofen | |
|---|---|---|
| Active Substances | DICLOFENAC SODIUM | IBUPROFEN |
| ATC Code | D11AX18 | C01EB16 |
| Form | SOLUTION/ DROPS | TABLET, COATED |
| Dosage | 1 mg/mL | 200 mg/1 |
| Route | OPHTHALMIC | ORAL |
| Manufacturer | Altaire Pharmaceuticals Inc. | Haleon US Holdings LLC |
| Indications | ( ARTG ) The suppression of voluntary muscle spasm in: multiple sclerosis, spinal lesions of traumatic, infectious, degenerative, neoplastic and unknown origin, causing: Skeletal hypertonus, Spastic and dyssynergic bladder dysfunction. Baclofen is not recommended in Parkinson's disease or spasticity arising from strokes, cerebral palsy or rheumatoid disorders. | — |
| Side Effects | You can help ensure medicines are safe by reporting the side effects you experience. You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems |
Diclofenac (INN: DICLOFENAC SODIUM, ATC D11AX18) and Ibuprofen (INN: IBUPROFEN, ATC C01EB16) differ in active substance, indications, and safety profile. The table above summarizes the clinical differences from regulatory documents.
Combination safety depends on mechanisms and your health profile. Use our interactions checker and always consult your doctor or pharmacist before combining medications.
Both drugs are approved when used per label. Safety is patient-specific — the better choice depends on your condition, other medications, allergies, and comorbidities. Consult a healthcare professional for personalized advice.
This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.
| — |
| Warnings | ( AHT ) This medicine contains the active ingredients: diclofenac If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people . | — |
|---|